In light of these data, our observation of significantly increased GAA levels in grade 4 gliomas as compared with lower grades appears relevant but will need to be verified and explained in future studies, in addition to the potential involvement of GAMT in the GAA overexpression. This evidence concerns the gene GAMT and central nervous system cancer.